Iovance Biotherapeutics Inc
(NAS:IOVA)
$
9.32
-0.08 (-0.85%)
Market Cap: 2.84 Bil
Enterprise Value: 2.52 Bil
PE Ratio: 0
PB Ratio: 3.67
GF Score: 39/100 Iovance Biotherapeutics Inc at Stifel Healthcare Conference (Virtual) Transcript
Nov 17, 2021 / 04:20PM GMT
Release Date Price:
$19.42
(-1.22%)
Benjamin Jay Burnett
Stifel, Nicolaus & Company, Incorporated, Research Division - Associate
Welcome, everyone, to our next panel. My name is Ben Burnett, biotech analyst at Stifel, and I'm pleased to be joined by Madan Jagasia, SVP of Medical Affairs; and Jean-Marc Bellemin, CFO of Iovance Biotherapeutics. So thank you both for being here.
Jean;Marc Bellemin
Iovance Biotherapeutics, Inc. - CFO & Principal Accounting Officer
Thank you, Ben, for having us.
Benjamin Jay Burnett;Jean;Marc Bellemin
Stifel, Nicolaus & Company, Incorporated, Research Division - Associate
We will do a fireside chat. But obviously, for folks who are dialing in, please feel free to submit questions to the dashboard. I will be monitoring that or e-mail me at [email protected]. So let's just kick it off. Can you maybe just give us a quick update on Iovance where things are, just flag sort of what you think are near-term catalysts that we should be watching out for?
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot